Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Caimi

Showing results (41-50 of 115) with videos related to

Pageof 12
Sort By:
Cell Death and Differentiation|March 20, 2010
Inhibition of Lck enhances glucocorticoid sensitivity and apoptosis in lymphoid cell lines and in chronic lymphocytic leukemiaM W Harr, P F Caimi, K S McColl, et al.
Clinical and Experimental Dermatology|February 17, 2015
Multiple skin cancers in a patient within 1 year of allogeneic haematopoietic cell transplant for chronic lymphocytic leukaemiaR Vyas, E K Gotow, J L DePry, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 17, 2022
The AntiCD19 Antibody Drug Immunoconjugate Loncastuximab Achieves Responses in DLBCL Relapsing After AntiCD19 CAR-T Cell TherapyPaolo F Caimi, Kirit M Ardeshna, Erin Reid, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|May 22, 2014
Prognostic information and biological insights in chronic lymphocytic leukemia by high-resolution immunophenotypic analysis of ZAP70David Kaplan, Zhuoxin Sun, Martin S Tallman, et al.
Bone Marrow Transplantation|March 28, 2017
Nivolumab before and after allogeneic hematopoietic cell transplantationF Covut, R Pinto, B W Cooper, et al.
Future Oncology (London, England)|November 12, 2024
Loncastuximab tesirine in previously treated diffuse large B-cell lymphoma: A plain language summary of the LOTIS-2 studyMehdi Hamadani, Paolo F Caimi, Brian Hess, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 2, 2015
Trends and Disparities in Cardiovascular Mortality Among Survivors of Hodgkin LymphomaSadeer G Al-Kindi, Ghaith F Abu-Zeinah, Chang H Kim, et al.
Hematological Oncology|June 13, 2023
A population level analysis of second hematological malignancies in chronic lymphocytic leukemia/small lymphocytic lymphoma survivors in the era of targeted therapiesRahul Mishra, Danai Dima, Sumukh A Kumar, et al.
Journal of Applied Clinical Medical Physics|October 13, 2019
Organ sparing of linac-based targeted marrow irradiation over total body irradiationGregory R Warrell, Valdir C Colussi, Wayne L Swanson, et al.
Clinical Transplantation|July 22, 2015
Neoplastic and non-neoplastic complications of solid organ transplantation in patients with preexisting monoclonal gammopathy of undetermined significanceTeresa E Goebel, Nicholas K Schiltz, Kenneth J Woodside, et al.
Pageof 12

Showing results (41-50 of 115) with videos related to

Sort By:
Pageof 12
Cell Death and Differentiation|March 20, 2010
Inhibition of Lck enhances glucocorticoid sensitivity and apoptosis in lymphoid cell lines and in chronic lymphocytic leukemiaM W Harr, P F Caimi, K S McColl, et al.
Clinical and Experimental Dermatology|February 17, 2015
Multiple skin cancers in a patient within 1 year of allogeneic haematopoietic cell transplant for chronic lymphocytic leukaemiaR Vyas, E K Gotow, J L DePry, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 17, 2022
The AntiCD19 Antibody Drug Immunoconjugate Loncastuximab Achieves Responses in DLBCL Relapsing After AntiCD19 CAR-T Cell TherapyPaolo F Caimi, Kirit M Ardeshna, Erin Reid, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|May 22, 2014
Prognostic information and biological insights in chronic lymphocytic leukemia by high-resolution immunophenotypic analysis of ZAP70David Kaplan, Zhuoxin Sun, Martin S Tallman, et al.
Bone Marrow Transplantation|March 28, 2017
Nivolumab before and after allogeneic hematopoietic cell transplantationF Covut, R Pinto, B W Cooper, et al.
Future Oncology (London, England)|November 12, 2024
Loncastuximab tesirine in previously treated diffuse large B-cell lymphoma: A plain language summary of the LOTIS-2 studyMehdi Hamadani, Paolo F Caimi, Brian Hess, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 2, 2015
Trends and Disparities in Cardiovascular Mortality Among Survivors of Hodgkin LymphomaSadeer G Al-Kindi, Ghaith F Abu-Zeinah, Chang H Kim, et al.
Hematological Oncology|June 13, 2023
A population level analysis of second hematological malignancies in chronic lymphocytic leukemia/small lymphocytic lymphoma survivors in the era of targeted therapiesRahul Mishra, Danai Dima, Sumukh A Kumar, et al.
Journal of Applied Clinical Medical Physics|October 13, 2019
Organ sparing of linac-based targeted marrow irradiation over total body irradiationGregory R Warrell, Valdir C Colussi, Wayne L Swanson, et al.
Clinical Transplantation|July 22, 2015
Neoplastic and non-neoplastic complications of solid organ transplantation in patients with preexisting monoclonal gammopathy of undetermined significanceTeresa E Goebel, Nicholas K Schiltz, Kenneth J Woodside, et al.
Pageof 12